Skip to main content
  • Sections
  • Search

Center for Strategic & International Studies

User menu

  • Subscribe
  • Sign In

   Ranked #1 Think Tank in U.S. by Global Go To Think Tank Index

Topics

  • Climate Change
  • Cybersecurity and Technology
    • Cybersecurity
    • Data Governance
    • Intelligence, Surveillance, and Privacy
    • Military Technology
    • Space
    • Technology and Innovation
  • Defense and Security
    • Counterterrorism and Homeland Security
    • Defense Budget
    • Defense Industry, Acquisition, and Innovation
    • Defense Strategy and Capabilities
    • Geopolitics and International Security
    • Long-Term Futures
    • Missile Defense
    • Space
    • Weapons of Mass Destruction Proliferation
  • Economics
    • Asian Economics
    • Global Economic Governance
    • Trade and International Business
  • Energy and Sustainability
    • Energy, Climate Change, and Environmental Impacts
    • Energy and Geopolitics
    • Energy Innovation
    • Energy Markets, Trends, and Outlooks
  • Global Health
    • Family Planning, Maternal and Child Health, and Immunizations
    • Multilateral Institutions
    • Health and Security
    • Infectious Disease
  • Human Rights
    • Civil Society
    • Transitional Justice
    • Human Security
  • International Development
    • Food and Agriculture
    • Governance and Rule of Law
    • Humanitarian Assistance
    • Private Sector Development
    • U.S. Development Policy

Regions

  • Africa
    • North Africa
    • Sub-Saharan Africa
  • Americas
    • Caribbean
    • North America
    • South America
  • Arctic
  • Asia
    • Afghanistan
    • Australia, New Zealand & Pacific
    • China
    • India
    • Japan
    • Korea
    • Pakistan
    • Southeast Asia
  • Europe
    • European Union
    • NATO
    • Post-Soviet Europe
    • Turkey
  • Middle East
    • The Gulf
    • Egypt and the Levant
    • North Africa
  • Russia and Eurasia
    • The South Caucasus
    • Central Asia
    • Post-Soviet Europe
    • Russia

Sections menu

  • Programs
  • Experts
  • Events
  • Analysis
    • Blogs
    • Books
    • Commentary
    • Congressional Testimony
    • Critical Questions
    • Interactive Reports
    • Journals
    • Newsletter
    • Reports
    • Transcript
  • Podcasts
  • iDeas Lab
  • Transcripts
  • Web Projects

Main menu

  • About Us
  • Support CSIS
    • Securing Our Future
Report
Share
  • LinkedIn
  • Facebook
  • Twitter
  • Email
  • Printfriendly.com

Global Health Interventions for U.S. Food and Drug Safety

November 13, 2009

In 2007, a series of high-profile scandals involving contaminated blood thinner, toxic toothpaste, and melamine-laced pet food demonstrated the threat that unsafe food and drug imports pose to U.S. public health and international trade. Contaminated and adulterated products have sickened and killed U.S. consumers, fueled protectionism, raised business costs, and destabilized markets. A 2008 public opinion poll found that 67 percent of Americans are worried about food safety, ranking it higher than concerns about pandemic flu or natural disasters.

Food and drug safety also has the attention of U.S. policymakers. In 2007, the Bush administration convened an Import Safety Working Group that called for an increased focus on prevention, more resources and greater mandates for the Food and Drug Administration (FDA) and other U.S. regulators, and increased engagement with trading partners and industry. President Obama appointed a cabinet-level Food Safety Working Group and requested the largest-ever budget increase for FDA food programs. The House of Representatives recently passed food safety legislation to modernize the authorities of the FDA and improve the ability of the FDA to trace and register facilities that import food, issue mandatory food recalls, and conduct border surveillance and enforcement. The Senate is scheduled to take up the food safety legislation in the coming weeks. Drug safety bills, pending in the House and Senate, would increase the mandate and resources for the FDA to conduct inspections of foreign drug suppliers.

Increasing the resources and mandate of U.S. regulators to conduct border and foreign risk-based inspections are positive and necessary steps, but insufficient. There are legal and practical limits to the ability of U.S. regulatory authorities to conduct inspections of foreign food and drug producers and suppliers. The scale and complexity of the global trade in food and drugs overwhelm traditional methods of border control and inspection at ports of entry. Ensuring the safety of U.S. food and drug imports requires new approaches as well as new resources for traditional interventions.

Downloads
Global Health Interventions for U.S. Food and Drug Safety
Thomas J. Bollyky
Media Queries

Contact H. Andrew Schwartz
Chief Communications Officer
Tel: 202.775.3242

Contact Caleb Diamond
Media Relations Manager and Editorial Associate
Tel: 202.775.3173

Related
Economics, Family Planning, Maternal and Child Health, and Immunizations, Global Health, Global Health Policy Center
Footer menu
  • Topics
  • Regions
  • Programs
  • Experts
  • Events
  • Analysis
  • Web Projects
  • Podcasts
  • iDeas Lab
  • Transcripts
  • About Us
  • Support Us
Contact CSIS
Email CSIS
Tel: 202.887.0200
Fax: 202.775.3199
Visit CSIS Headquarters
1616 Rhode Island Avenue, NW
Washington, DC 20036
Media Queries

Contact H. Andrew Schwartz
Chief Communications Officer
Tel: 202.775.3242

Contact Caleb Diamond
Media Relations Manager and Editorial Associate
Tel: 202.775.3173

Daily Updates

Sign up to receive The Evening, a daily brief on the news, events, and people shaping the world of international affairs.

Subscribe to CSIS Newsletters

Follow CSIS
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Instagram

All content © 2020. All rights reserved.

Legal menu
  • Credits
  • Privacy Policy
  • Reprint Permissions